EK-12

· Bosnalijek D.D.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EK-12, covering 2024-08-13 to 2024-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS [Phase 3]

See pricing